Abstract
Over the past decade, numerous studies have found an association between the gut microbiota composition and many diseases. However, is it reality? Or is the truth hidden in the shadow of several thousand publications a year with inflated expectations in almost any disease?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention
Diabetologia Open Access 28 October 2023
-
Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox
Genome Biology Open Access 30 March 2021
-
Diesel exhaust particles alter the profile and function of the gut microbiota upon subchronic oral administration in mice
Particle and Fibre Toxicology Open Access 09 February 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout

References
Sender, R., Fuchs, S. & Milo, R. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164, 337–340 (2016).
Thaiss, C. A. et al. Microbiota diurnal rhythmicity programs host transcriptome oscillations. Cell 167, 1495–1510.e12 (2016).
Brown, J. M. & Hazen, S. L. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu. Rev. Med. 66, 343–359 (2015).
Plovier, H. et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23, 107–113 (2017).
Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022–1023 (2006).
Cani, P. D. & Everard, A. Talking microbes: when gut bacteria interact with diet and host organs. Mol. Nutr. Food Res. 60, 58–66 (2016).
Skyler, J. S. et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes 66, 241–255 (2017).
[No authors listed.] Standards of medical care in diabetes — 2017: summary of revisions. Diabetes Care 40, S4–S5 (2017).
Hanage, W. P. Microbiology: microbiome science needs a healthy dose of scepticism. Nature 512, 247–248 (2014).
Acknowledgements
P.D.C. is a research associate at FRS-FNRS (Fonds de la Recherche Scientifique) and the recipient of grants from FNRS (convention J.0084.15, convention 3.4579.11), PDR (Projet de Recherche, convention: T.0138.14) and Walloon region DG06-FSO project (Microbes 1510053). His work is supported by the FRFS-WELBIO under grant: WELBIO-CR-2012S-02R, and, in part, by the Funds Baillet Latour (Grant for Medical Research 2015). P.D.C. is a recipient of POC ERC grant 2016 (European Research Council, Microbes4U_713547) and ERC Starting Grant 2013 (Starting grant 336452-ENIGMO).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Cani, P. Gut microbiota — at the intersection of everything?. Nat Rev Gastroenterol Hepatol 14, 321–322 (2017). https://doi.org/10.1038/nrgastro.2017.54
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2017.54
This article is cited by
-
Impact of metformin and Dysosmobacter welbionis on diet-induced obesity and diabetes: from clinical observation to preclinical intervention
Diabetologia (2023)
-
Association of microbiota with cancer treatment
International Journal of Clinical Oncology (2023)
-
Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
Nature Reviews Gastroenterology & Hepatology (2022)
-
Metronidazole and ciprofloxacin differentially affect chronic unpredictable mild stress-induced changes in the colon, cecum and ileum microbiota
Applied Microbiology and Biotechnology (2022)
-
Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox
Genome Biology (2021)